| Financial Year |
March 31 2023 |
| Monetary Funds |
84,960,709.82 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
117,611,560.19 |
| Advances to Suppliers |
7,039,237.03 |
| Other Receivables |
2,282,591.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
467,125,058.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,395,989.55 |
| Total Current Assets |
691,335,146.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
629,895,643.03 |
| Under-construction Projects |
820,517,482.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,849,545.43 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
164,038.64 |
| Other Non-Current Assets |
166,886,173.06 |
| Sub-Total of Non-Current Assets |
1,641,779,093.53 |
| Total Assets |
2,333,114,239.79 |
| Short-Term Loans |
308,841,416.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
96,590,842.40 |
| Accounts Payable |
66,775,640.70 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,624,872.23 |
| Taxes Payable |
3,178,489.35 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
47,338,383.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,059,462.72 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
556,211,644.04 |
| Long-term Loans |
376,333,318.70 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
32,776,923.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
415,789,627.77 |
| Total Liabilities |
972,001,271.81 |
| Paid-In Capital(Or Share Stock) |
350,264,883.00 |
| Capital Surplus |
552,237,148.43 |
| Surplus Reserve |
51,127,608.79 |
| LESS:Treasury Stock |
42,004,201.00 |
| Undistributed Profits |
449,487,528.76 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,361,112,967.98 |
| Owner's Equity（Stockholder's Equity） |
1,361,112,967.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,333,114,239.79 |
